Advertisement

Just days after naming a new executive to handle international growth, NxStage Medical Inc. said it has won approval for its NxStage System One dialysis product from Australia’s Therapeutic Goods Administration (TGA). In addition, the company has signed a five-year agreement with Regional Health Care Group, a medical products distributor in Australia and New Zealand.

The new agreement with RHCG — the first year of which is an exclusive one — will allow RHCG the rights to sell the NxStage System One and the PureFlow dialysate preparation system from NxStage to dialysis centers in Australia and New Zealand.

SOURCE

Advertisement
Advertisement